IMMUNOTECH-B News

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 6 16:40

IMMUNOTECH-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 24 MAY 2024

Apr 29 17:01

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 3 16:46

IMMUNOTECH-B: PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE FOURTH MEMORANDUM AND ARTICLES OF ASSOCIATION

Mar 28 21:39

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 5 20:30

IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENT THE CLINICAL TRIAL APPROVAL FOR THE aT19 INJECTION

Feb 19 19:32

IMMUNOTECH-B: Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications

Feb 5 16:46

IMMUNOTECH-B: Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications

Feb 5 16:45

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 2 17:20

IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE PHASE II CLINICAL TRIAL FOR CAR-T-19 INJECTION

Jan 3 19:33

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 3 16:40

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 4, 2023 17:26

IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENT RECEIPT OF THE ACCEPTANCE NOTICE FOR THE INVESTIGATIONAL NEW DRUG APPLICATION FOR THE aT19 INJECTION

Nov 24, 2023 19:17

IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE PHASE I CLINICAL TRIAL FOR THE DENOCABTAGENE CILOLEUCEL INJECTION

Nov 7, 2023 17:30

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023

Nov 3, 2023 17:23

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023

Oct 6, 2023 16:40

IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENT EAL WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR TREATMENT OF LIVER CANCER BY THE CENTER FOR DRUG EVALUATION

Sep 5, 2023 18:29

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023

Sep 5, 2023 16:35

IMMUNOTECH-B: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

Aug 27, 2023 18:31

IMMUNOTECH-B: APPOINTMENT AND RESIGNATION OF DIRECTORS

Aug 27, 2023 18:30